 Epidemiologic clinical aspects insulin resistance hyperinsulinemia Epidemiologic studies insulin risk factor coronary heart disease CHD Clinical studies positive correlations insulin blood pressure triglycerides total cholesterol fibrinogen plasminogen activator inhibitor inverse correlation insulin high-density lipoprotein HDL studies evidence support biologic plausibility epidemiologic observations insulin role pathogenesis human cardiovascular diseases CVD hypertension fact considerable evidence insulin resistance abnormal nonoxidative glucose disposal hyperinsulinemia primary insulin-related abnormality human hypertension hyperinsulinemia response resistance Skeletal muscle primary site insulin resistance essential hypertension organs kidneys liver key sites cell water homeostasis lipoprotein regulation Adipocytes site insulin resistance putative interrelationship hyperinsulinemia insulin resistance hand blood pressure lipoproteins complex organ-specific insulin resistance Altered cation transport several mechanisms insulin resistance blood pressure Na+ -ATPase Ca -ATPase pumps insulin sensitive insulin resistance present activity pumps smooth muscle arterial wall intracellular accumulation sodium calcium vascular wall substances secondary hyperinsulinemia insulin sympathetic nervous system activity renal tubular absorption sodium Insulin growth factor trophic effect vessel wall sustain hypertension atherosclerosis Abnormal lipoprotein metabolism possible explanation accelerated atherosclerosis persons abnormal carbohydrate tolerance insulin resistance Hyperinsulinemia insulin resistance role expression elevated very-low-density lipoprotein VLDL low-density lipoprotein LDL levels depression HDL levels Coronary risk reduction blood pressure treatment regimens thiazide diuretics beta blockers Thiazides beta blockers tissue insulin sensitivity blood lipoprotein abnormalities ABSTRACT TRUNCATED AT WORDS